CT scan analysis for ovarian cancer treatment planning
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study uses advanced computer analysis of CT scans to help doctors plan the best treatment for advanced ovarian cancer. It is designed for patients who are about to start active treatment, such as surgery or chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have suspected or confirmed advanced ovarian cancer (FIGO stage 3B or higher).
- You must be planning to have active treatment, like surgery followed by chemotherapy, or chemotherapy before surgery.
- You must have had a CT scan with contrast before starting treatment for ovarian cancer, and that scan must show a tumor at least 2 cm in size.
- You must be able to have a CT scan with contrast (no severe allergies, kidney failure, or other issues).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a computer program (artificial intelligence) that looks at CT scans of the pelvis to help find ovarian cancer. If it works, it could help doctors diagnose this cancer earlier and more accurately.
This study uses two types of PET/CT scans (68Ga-FAPI-46 and 18F-FDG) to look for any returning ovarian cancer. The goal is to find recurrence early so you and your doctor can plan the next steps.
This study uses ultrasound to look at how ovarian cancer affects the liver, helping doctors plan surgery better. By taking detailed pictures of the liver before surgery, they hope to improve outcomes for people with advanced or recurrent ovarian cancer.
This study looks at how medical images relate to genetic patterns in high-grade serous ovarian cancer. It may help find better ways to diagnose and treat this specific type of ovarian cancer.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
This trial tests a new imaging method that uses a special tracer (like a dye) to light up ovarian cancer cells on a PET/CT scan. It aims to help doctors see the cancer more clearly and to check whether treatment is working, which could lead to better care for people with advanced or recurrent ovarian cancer.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.